baber/WOPTO huggingface dataset:
Patent JP-2002505572-A (JP)
IPC: C12N9/16
Filed: 1998-03-20
Abstract: The invention provides novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases. Included within the aspects of the invention are methods for identifying compositions with a polymerase enhancing activity, methods for purifying and using these compositions, and specific extracts, proteins, and complexes that function to enhance polymerase activity. As an example, specifically described is nucleotide and amino acid sequence information for a Pyrococcus furiosus PEF (P45), which was used to produce a recombinant PEF.
Patent JP-2001523418-A (JP)
IPC: H04W36/18
Filed: 1998-04-29
Abstract: A method and apparatus for operating a cellular telephone system that supports performing an inter-system soft handoff is described. A subscriber unit generates a pilot strength measurement report when the pilot channel from a base station is detected. When a base station controller receiving the pilot strength measurement report determines that the base station is part of a second cellular telephone system, a inter-system soft handoff request is generated. An admission control subsystem receives the inter-system soft handoff and either grants or denies the request base on the traffic level with the second cellular telephone system. In a preferred embodiment of the invention, the traffic level is determined based on link load messages received periodically by the admission control subsystem that are generated by an interface port coupled to an interconnect between the first cellular telephone system and the second cellular telephone system. The link load message include peak queue length and average frame rate information.
Patent NO-5744-A (NO)
Inventor: WELCH BRUCE
IPC: C08F4/642
Filed: 2000-11-13
Abstract: A method for preparing a solid catalyst system comprising at least one metallocene, which at least one metallocene is 5-(9-fluorenyl)-5-(cyclopentadienyl)-hexene-1 zirconium dichloride, the method comprising   (a) combining an organoaluminoxane and said at least one metallocene in a liquid to form a liquid catalyst system, (b) conducting prepolymerization of at least one olefin in the presence of said liquid catalyst system to produce a prepolymerized solid catalyst, and (c) separating the resulting solid from the liquid and components dissolved in said liquid.
Patent NZ-198682-A (NZ)
Title: Polymerisation of vinyl chloride:build-up suppressant coating on internal surfaces of reactor
Inventor: WALKER R W
IPC: C23F15/00
Filed: 1981-10-19
Abstract: Polymerization of vinyl chloride in aqueous suspension using a polymerization reactor having adherently deposited on internal surfaces thereof a build-up suppressant coating comprising a product of build-up suppressant activity formable by (and preferably formed by) the condensation of an effective 1-naphthol (preferably 1-naphthol itself) and formaldehyde. The condensation is preferably effected in a base-catalyzed reaction; it may also (less preferably) be effected in an acid-catalyzed reaction. The coating product itself and a process for its production are also claimed.
Patent NZ-208283-A (NZ)
Title: Peptide derivatives and pharmaceutical composition
Inventor: HARDY G W
IPC: C07K5/10
Filed: 1984-05-25
Abstract: Novel peptides of formula (I)whereinR' is hydrogen, alkyl of 1 or 2 carbon atoms or an amidino group,R<sup>2</sup> is alkyl of 1 or 2 carbon atoms,R<sup>3</sup> is hydrogen or carbamyl,X<sup>2</sup> is a D-radical having the structure:Z<sup>1</sup> and Z<sup>2</sup> are the same or different and each is hydrogen, halo, nitro or trifluoromethyl and at least one is other than hydrogen,m is 2, 3 or 4 andn is 0,1 or 2, provided that when R' is carbamyl then n is always 1; and salts thereof.The compounds have a selectively peripheral analgesic effect when administered to mammals and also exhibit antidiarrhoeal and ant<sup>i</sup>tussive activity and may thus be used in human or veterinary medicine for the relief or prevention of pain, for the treatment of diarrhoea or dysentery and for the suppression of cough.
Patent NZ-209462-A (NZ)
Title: Pulse generated: gated reference level replaces pulse base level
Inventor: RABAEY D H L C
IPC: H04M15/00
Filed: 1984-09-06
Abstract: The present invention relates to electronic circuits and signal generator using them. The signal generator is adapted to generate a signal with pulses having sloping edges and includes a generator circuit (BSG) which is adapted to give the signal (BS+) in the time intervals between the pulses such an amplitude with respect to a second signal (BS-) that this amplitude may be detected by a detector circuit (CO) and in response thereto may be limited by a limiting circuit (S4) to a reference value. The electronic circuits include a comparator circuit (CO) and a modulator circuit (MOD).
Patent NZ-216833-A (NZ)
Title: Producing ceramic polycrystalline corundum abrasive
Inventor: BARTELS G
IPC: B24D3/00
Filed: 1986-07-14
Abstract: 1. A method for the production of an abrasive containing ceramic, polycrystalline, alpha-alumina and spinel by de-watering, calcining and sintering a dispersion which comprises a first preliminary phase containing an aluminium hydroxide and a spinel former, characterised in that the dispersion comprises a second preliminary phase containing gamma-alumina.
Patent NZ-216897-A (NZ)
Title: A delayed and sustained release composition with polymeric carrier
Inventor: ZIERENBERG BERND
IPC: A61K9/20
Filed: 1986-07-18
Abstract: The pharmaceutical composition is in the form of a carrier material with a pharmaceutical agent with controlled and delayed release of agent. The release of the agent can be adjusted by varying the particle size and the glass transition temperature.
Patent NZ-233206-A (NZ)
Title: Detecting peak value in flywheel circuit
Inventor: STEINHAGEN WOLFGANG
IPC: G08C19/00
Filed: 1990-04-04
Abstract: A circuit arrangement is described with the aid of which a control signal can be generated in dependence upon the occurrence of an extreme value of a sinusoidal oscillation. The circuit arrangement (10) includes a storage member (22) which is adapted to be charged via a diode (20) to one of the extreme values of the sinusoidal oscillation. A discharge path (26) for the storage member (22) is present, the time constant of which is so dimensioned that within the period duration of the sinusoidal oscillation an appreciable discharge of the storage member (22) takes place. A switch element (24) controllable by the charge voltage of the storage member (22) furnishes the control signal at its output (14) for the period of time during which the charge voltage at the storage member (22) is smaller than the extreme value of the sinusoidal oscillation. The circuit arrangement can be used in maintaining the oscillations of a resonance circuit stimulated to oscillate by means of a momentary HF carrier wave pulse, for instance in a transponder circuit. <IMAGE>
Patent NZ-234486-A (NZ)
Title: Aerosol dispenser with frusto-conical diverter to separate the propellant from the aerosol droplets
Inventor: PRITCHARD JOHN NIGEL
IPC: A61M11/00
Filed: 1990-07-12
Abstract: An aerosol dispenser, for example an inhaler, consists of a container (12) containing a propellant and a medicament, with a valve (14), and an applicator (16). The applicator includes a frusto-conical diverter (20) with a small orifice (60) facing the valve orifice (37). Aerosol droplets predominantly pass through the small orifice, decelerate, and can then be inhaled, while the propellant gas is predominantly diverted out of the applicator.
Patent NZ-240530-A (NZ)
Title: Gland fastened to machine housing by bolt tabs in circumferential dovetail channel
Inventor: AZIBERT HENRI V
IPC: F16J15/24
Filed: 1991-11-08
Abstract: A universal gland having a central opening for mounting coaxially about a machine shaft and adapted for mounting to a machine housing (55), through which the shaft extends, by a plurality of bolts (50) at bolt hole positions in the housing, characterized in that the gland comprises a gland body (12, 14) extending radially at the bolt hole positions a distance less than the minimum radial distance of the bolt hole positions from the axis of the shaft the gland further comprises a plurality of bolt mounting tabs (30) extending radially beyond the periphery of the gland body a distance at least to the bolt hole positions the tabs are angularly adjustable about the gland body; and the gland body comprises a mounting surface (16) for placement adjacent the housing and facing away from the mounting surface at least one tab engaging surface (25) engaged by the tabs for transferring forces from the bolts to the gland body is disclosed. <IMAGE>
Patent NZ-240814-A (NZ)
Title: Soluble coffee: liquid carbon dioxide used as an extraction agent.
Inventor: VITZTHUM OTTO G
IPC: A23F5/18
Filed: 1991-11-29
Abstract: The invention relates to a process for preparing soluble coffee in which, to eliminate off-flavour substances, one or more extracts occurring during the aqueous extraction of roast coffee are extracted fully or partly at a temperature of approximately 20 to 120  DEG C and a pressure of approximately 60 to 400 bar with supercritical or liquid CO2.
Patent NZ-242040-A (NZ)
Title: Process for the enantiomeric enrichment of a mixture of d- and l-threo 2-amino-3-hydroxy-3-phenyl propionic acids by the use of d-threonine aldolase
Inventor: ZEITLIN ANDREW L
IPC: C12P13/04
Filed: 1992-03-18
Abstract: Mixtures of enantiomeric D,L-threo 2-amino-3-hydroxy-3-phenylpropionic acids can be stereoisomerically enriched by contacting the mixture with a D-threonine aldolase. In a typical embodiment, D- and L-threo 2-amino-3-hydroxy-3-(4-methylsulfonylphenyl)propionic acid is treated with D-threonine aldolase to produce L-threo 2-amino-3-hydroxy-3-(4-methylsulfonylphenyl)propionic acid with a high ee. The benzaldehyde and amino acid formed from the D-threo isomer can be recycled.
Patent NZ-247765-A (NZ)
Title: Heterocyclic substituted hydroxamic acid derivatives; their preparation and medicaments and intermediates therefor
Inventor: BROADHURST MICHAEL JOHN
IPC: A61K38/00
Filed: 1993-06-02
Abstract: The invention provides hydroxamic acid derivatives of the formula   <CHEM> wherein R<1> represents a 5- or 6-membered N-heterocyclic ring, R<2> and R<3> each represent lower alkyl or NR<2>R<3> represents a saturated 5-, 6- or 7-membered heterocyclic ring, R<4>, R<5>, R<6> and R<7> each represent hydrogen or methyl, provided that at least two of these symbols represent hydrogen and n stands for 1-4, and their pharmaceutically acceptable salts, which are collagenase inhibitors useful for the control or prevention of degenerative joint diseases such as rheumatoid arthritis and osteoarthritis or for the treatment of invasive tumours, atherosclerosis or multiple sclerosis.
Patent NZ-292683-A (NZ)
Title: Piperidine derivatives
Inventor: BURKHOLDER TIMOTHY PAUL
IPC: A61K31/535
Filed: 1995-08-17
Abstract: The present invention relates to novel substituted piperidine derivatives of the formulastereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic diseases including: seasonal rhinitis, allergic rhinitis, and sinusitis.
Patent NZ-330553-A (NZ)
Title: Recombinase-mediated generation of adenoviral vectors where all adenoviral genes of all regions E1 to E4 and L1 to L5 of the adenoviral genome are eliminated
Inventor: KALEKO MICHAEL
IPC: A61K48/00
Filed: 1997-01-03
Abstract: A method for generating adenoviral vectors from polynucleotides such as plasmids wherein there occurs a recombinase-mediated transfer of an adenoviral ITR and terminal proteins bound to the ITR to a plasmid, thus enabling the plasmid to replicate as an adenoviral vector. Such a method enables the rapid generation of adenoviral vectors at high titers from plasmids without the use of selectable markers and screening procedures.  Such method enables the rapid generation of adenoviral vectors devoid of adenovirus backbone genes. The method also may be employed to generate hybrid adenoviral-retroviral vectors that convert transduced cells into producer cells that produce retroviral vectors to effect high level, permanent genetic modification of cells in vivo.  The method may prelude the advent of human gene therapy.
Patent NZ-331061-A (NZ)
Title: Trigger-type liquid dispenser having non-moveable trigger when nozzle head is positioned in off position
Inventor: WATANABE NORITOSHI
IPC: B05B11/00
Filed: 1997-10-22
Abstract: trigger type liquid sprayer comprises a mount cylinder (2) fitted onto a neck portion of a container body.  A vertical cylinder (2a) is provided upright on mount cylinder (2) and a jetting cylinder (3) projects forward from an upper end of vertical cylinder (2a) and a cylinder (4) projects forward from an intermediate portion of vertical cylinder (2a).  A plunger (6) is slidably fitted in cylinder (4) and is biased forward.  The sprayer has a trigger (5) and a rear surface of an upper portion of which engages with a forward end of the plunger (6) and which is swingably mounted to a forward end of the jetting cylinder (3).  A nozzle fitting cylinder (7) is mounted to a forward end of the jetting cylinder (3), and a nozzle head (8) is formed with nozzle holes (10) and is rotatably mounted to an outer surface of the nozzle fitting cylinder (7).  An arm (21) projects rearward from an outer surface of the nozzle head (8).  A first engaging portion (23) is provided on an upper portion of the trigger (5), and a second engaging portion (26) is provided on a forward surface of a lower portion of the cylinder (4).  When the trigger (5) is positioned at a foremost location and the nozzle head (8) is turned, a portion of the arm (21) detachably engages with the first engaging portion (23), and the other portion of the arm (21) detachably engages with the second engaging portion (26), whereby the plunger (6) will not move rearward even when a user attempts to pull the trigger (5).
Patent NZ-331660-A (NZ)
Title: Process for the preparation of water soluble brine dispersion polymers
Inventor: CONNORS EDWARD J
IPC: C08F220/56
Filed: 1997-05-21
Abstract: A process for preparing a water-soluble polymer dispersion is herein provided which is characterized by polymerizing from about 10 to 50 mole percent of a monomer having a formula (II); from about 1 to 50 mole percent of N-alkylacrylamide, N,N-dialkylacrylamide or mixtures thereof; having a formula (III) from about 1 to 70 mole percent acrylamide; and optionally up to about 4 mole percent of a monomer having a formula (I) having a benzyl functionality. The polymerization is carried out in the presence of an aqueous solution of a polyvalent anionic salt which contains (1) a water soluble cationic polymer which is insoluble in the aqueous salt solution and (2) a water soluble cationic polymer which is soluble in the aqueous salt solution.
Patent NZ-332737-A (NZ)
Title: Benzoxazinone dopamine D4 receptor antagonists
Inventor: BELLIOTTI THOMAS
IPC: C07D265/36
Filed: 1997-05-20
Abstract: These compounds, which are useful as antagonists of dopamine D4 receptors. Are of the formulae (I) or (II) where R1 and R2 are independently hydrogen or C1-C6 alkyl; X is N or CH; and R3 is phenyl, naphthyl, heteroaryl, substituted phenyl, substituted naphthyl or substituted heteroaryl, where each substituent is independently selected from halogen, C1-C6 alkoxy, C1-C6 alkyl, -CN, -CF3, or sulphonamido, and the pharmaceutically acceptable salts, esters, amides, and prodrugs thereof.
Patent NZ-504124-A (NZ)
Title: Phenyl-alkyl-imidazoles and use in treating inflammatory disease
Inventor: MCCORMICK KEVIN D
IPC: A61P37/08
Filed: 1998-11-05
Abstract: A composition of phenyl-alkyl-imidazole compounds of formula (I) or a pharmaceutically acceptable acid addition salt or tautomer, wherein A and R are as defined in the specification, and a histamine H1 receptor, for use in the treatment of upper airway allergic responses, by acting as an antagonist of the H3 receptor.
Patent NZ-505733-A (NZ)
Title: Investment casting mold having an aqueous colliodal silica sol with a particle size of 40 nanometer
Inventor: VANDERMEER JOHN
IPC: B22C1/08
Filed: 1999-02-09
Abstract: A process for rapidly forming a ceramic shell mold on an expendable pattern (not shown) is disclosed. The process entails use of refractory slurries which include a large particle size colloidal silica sol binder. The colloidal silica sol binder has an average particle size of about 40 nanometers, i.e., about 3-4 times larger than colloidal silica sol binders heretofore employed in manufacture of ceramic shell molds. The use of the large particle sols yields unfired ceramic shell molds (20) which have about 40 % to about 70 % greater unfired strengths compared to ceramic shells made with prior art small particle size silica sols. Prime coats and refractory back-up coats which use the large particle size sol dry about 30 % to about 40 % faster than prime coats and back-up coats which employ the smaller particle size silica sols of the prior art.
Patent NZ-506186-A (NZ)
Title: Fungicide composition comprising a benzoylphenylurea
Inventor: BEN-ZIONY YAIR
IPC: A61P31/10
Filed: 1999-01-26
Abstract: The use of a compound of formula I wherein R1 and R2 are each independently hydrogen, halogen or methoxy, for the manufacture of a medicament for the treatment of fungal infections in humans or animals caused by dermatophytes such as Microsporum, Trichophyton, Aspergillus or yeast.
Patent NZ-506320-A (NZ)
Title: Dispensing apparatus with needle nib insert
Inventor: MURPHY PETER JAMES
IPC: B41K1/00
Filed: 2000-08-11
Abstract: A dispenser capable of expressing liquid, whether a solution, suspension, emulsion, suspo- emulsion or a pure liquid compound, that comprises a chamber of variable volume that is able to drawing in a liquid via a liquid inlet.  When the volume of the chamber is reduced the liquid is expressed out through the outlet.  The dispenser also comprises a nib insert (11) that has a liquid passageway therethrough, being engaged fluid tight communication with the outlet.  A needle structure or other outlet member such as a catheter is mounted about the nib insert to receive liquid via the liquid passageway from the outlet. The outlet can have both an internal (9) and external (8) thread thereby allowing the engagement of the nib insert to the dispenser via the treaded portion around the outside of the nib (10) with a corresponding thread in a receiving region of the dispenser.  Alternatively the engagement of the needle nib insert with the dispenser is achieved by a "snap lock" engagement.
Patent NZ-509914-A (NZ)
Title: 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action for treating epileptic disorders and method for producing same
Inventor: BARTSCH RENI
IPC: C07D213/74
Filed: 1999-07-28
Abstract: Compounds of formula (I) are disclosed, wherein: X is hydrogen, C1-C4 alkyl, C1-C4 alkoxy, trifluoromethyl, trifluoromethoxy, or a halogen; and A is an amino, C1-C4 alkylamino, C1-C4 dialkylamino, morpholino, piperidino, or pyrrolidino, excepting compounds in which n=0 and A=methylamino or dimethylamino.  Also described are processes for the preparation of the above compounds.  Such compounds are useful for treating epileptic disorders of various forms.
Patent NZ-511672-A (NZ)
Title: Continuous process for preparing microgels using a deformable aging vessel
Inventor: MOFFETT ROBERT HARVEY
IPC: D21H17/68
Filed: 1999-09-13
Abstract: A continuous process for preparing a polysilicate microgel comprises in sequence: a) mixing in a water soluble silicate aqueous solution and a gel initiator in a mixing vessel to produce an aqueous mixture having a silica concentration of 0.5 to 15% by weight and b) aging the mixture in an elongated aging vessel to partially gel the mixture. The mixing vessel and/or the aging vessel are elastically deformable and are temporarily deformed during the process to dislodge deposits formed on the vessels walls and purge the deposits from the vessel.
Patent NZ-513792-A (NZ)
Title: A novel agropolymer used for purification of polluted water or contaminated water containing metal or ions and a method of producing the agropolymer
Inventor: PRASAD YANDAPALLI DURGA
IPC: C02F/
Filed: 2000-02-24
Abstract: An agropolymer comprising carbohydrate and/or silica matrix substantially devoid of at least proteins, tannins and polyphenols and having metal binding reactive sites.  A method of producing said agropolymers from plant material such as seed coats, husks or hulls of the various agricultural crops (Oryza sativa, Panicum miliaceum, Setaria italica, Cajanus cajan, Vigna mungo, Vigna radiata, Triticum sp., Ricinus communis, Helianthus annus, Gossypium sp. Arachis sp.), and a method of purifying of metal and ion polluted/contaminated aqueous solutions including metal or ion polluted drinking water or ground water using the said agropolymer.
Patent NZ-516550-A (NZ)
Title: Hybrid polypeptides with enhanced pharmacokinetic properties
Inventor: BARNEY SHAWN
IPC: A61K38/08
Filed: 2000-07-10
Abstract: A method for enhancing the pharmacokinetic properties of a core polypeptide comprising linking an enhancer peptide sequence to the core polypeptide to produce a hybrid polypeptide; wherein the enhancer peptide sequence comprises WXXWXXXI, WXXWXXX, WXXWXX, WXXWX, WXXW, WXXXWXWX, XXXWXWX, XXWXWX, XWXWX, WXWX, WXXXWXW, WXXXWX, WXXXW, IXXXWXXW, XXXWXXW, XXWXXW, XWXXW, XWXWXXXW, XWXWXXX, XWXWXX, XWXW, WXWXXXW OR XWXXXW; wherein the core polypeptide preferably comprises TALLEQAQIQQEKNEYELQKLDK; and wherein at least one amino acid residue of the hybrid polypeptide is polyol-conjugated such that when introduced into a living system the hybrid polypeptide exhibits enhanced pharmacokinetic properties relative to those exhibited by the core polypeptide.
Patent NZ-522623-A (NZ)
Title: A beta galactosidase with transglactosylase activity isolated from a bifidobacterium
Inventor: JORGENSEN FLEMMING
IPC: A23L33/00
Filed: 2001-05-25
Abstract: A DNA sequence that encodes an enzyme with transgalactosylase activity consists of a fragment of the coding region of SE ID NO:1. The coding region starts with ATG in position 212-214 and ends with TGA in position 5468- 5470. A beta-galactosidase sequence is defined in the amino acid sequence of SEQ ID NO:2. Also described are cells and vectors containing the DNA sequence and the use of the cells or enzymes in dairy products. The trans- galactosylating enzyme can be used it produce galacto- oligosaccharides to be used in dairy products or to enhance the growth of Bifidobacterium.
Patent NZ-526416-A (NZ)
Title: System for producing dried singulated cellulose pulp fibers using a jet drier and injected steam
Inventor: YANCEY MICHAEL JAMES
IPC: F26B20/00
Filed: 2003-06-11
Abstract: A drying system (10) for processing of pulp into a singulated and dried fibers comprising of a jet drier (20) with a jet conduit, a pulp intake (24) for delivery of pulp into the jet conduit, a manifold for air intake into the jet conduit, an injection port for steam, a fiber outlet (28) for removal of singulated and dried fibers, outlet air and fines from the jet conduit. A pulp supply station (40) coupled to the pulp intake for supplying a feed pulp to the pulp intake, the pulp supply station including a treatment supply (48) source for delivering a treatment substance to the pulp. An air supply station (90) coupled to the manifold (26) for delivering air to the manifold, an outlet flow conduit (30) coupled to the fiber outlet for removal of the fibers, outlet air, and fines from the jet conduit and a fiber separation station (100) coupled to the outlet flow conduit for separating the fibers from the outlet air.